Swiss National Bank
VERA icon

Swiss National Bank’s Vera Therapeutics VERA Stock Holding History

Swiss National Bank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.04M Hold
75,600
– – ﹤0.01% 1630
2025
Q4 		$3.83M Sell
75,600
-4,800
-6% -$170K ﹤0.01% 1502
2025
Q3 		$2.34M Sell
80,400
-5,000
-6% -$116K ﹤0.01% 1776
2025
Q2 		$2.01M Hold
85,400
– – ﹤0.01% 1809
2025
Q1 		$2.05M Hold
85,400
– – ﹤0.01% 1748
2024
Q4 		$3.61M Buy
85,400
+15,700
+23% +$695K ﹤0.01% 1513
2024
Q3 		$3.08M Hold
69,700
– – ﹤0.01% 1612
2024
Q2 		$2.52M Buy
69,700
+7,500
+12% +$297K ﹤0.01% 1691
2024
Q1 		$2.68M Buy
62,200
+13,500
+28% +$481K ﹤0.01% 1679
2023
Q4 		$749K Hold
48,700
– – ﹤0.01% 2382
2023
Q3 		$668K Buy
+48,700
New +$836K ﹤0.01% 2429
2023
Q1 		– Sell
-35,900
Closed -$695K – 2670
2022
Q4 		$695K Buy
35,900
+1,200
+3% +$21.7K ﹤0.01% 2492
2022
Q3 		$739K Hold
34,700
– – ﹤0.01% 2452
2022
Q2 		$472K Buy
+34,700
New +$606K ﹤0.01% 2619

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Swiss National Bank's VERA Position: Q1 2026 in Review

Swiss National Bank held its Vera Therapeutics (VERA) position steady in Q1 2026 at 75,600 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Swiss National Bank first reported a position in VERA in Q2 2022 and has held it in 14 quarters since. The position peaked at $3.83M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Swiss National Bank held 75,600 shares of Vera Therapeutics worth $3.04M as of Q1 2026.
  • Swiss National Bank left its Vera Therapeutics share count unchanged in Q1 2026.
  • Vera Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1630 holding.
  • Swiss National Bank first reported a position in Vera Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Swiss National Bank's Vera Therapeutics position peaked at $3.83M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.